Health Care/Hospital
Copan strengthens its operations in the Americas with a millionaire investment
Copan announces a $78 million investment to expand its Puerto Rican production site. The project – partially financed byPuerto Rico's Government – will bring Copan production and distribution capacity closer to the American market, strengthening the company's presence in the US and the rest of th...
2021-06-08 14:00
2051
Onward Therapeutics Signs an Exclusive Collaboration and Worldwide Option and License Agreement with Institut du Cancer de Montpellier
EPALINGES, Switzerland, June 8, 2021 /PRNewswire/ -- Onward Therapeutics (Onward) and Institut du Cancer de Montpellier (ICM) announced today the execution of an exclusive collaboration and worldwide option and license agreement based on a research program in onco-metabolism being conducted by I...
2021-06-08 12:00
1215
Cytiva opens experience and learning lab in Singapore
* New lab will support Singapore government's Industry 4.0 agenda to build research, digital, innovation capability and talent development * Part of Cytiva's capacity expansion plan to meet the increasing demands for the biopharmaceuticals industry * Through this lab, Cytiva intends to run 7...
2021-06-08 10:00
1685
CGTN: Peng Liyuan calls for global efforts in AIDS and TB prevention and treatment
BEIJING, June 8, 2021 /PRNewswire/ -- Peng Liyuan, wife of Chinese President Xi Jinping, called on people from all walks of life in all countries to join hands and take action to strengthen the prevention and treatment of AIDS and tuberculosis (TB), in order to benefit all mankind and build a glo...
2021-06-08 09:37
2441
Innovent Biologics and IASO Biotherapeutics to Present Updated Data from its Anti-BCMA CAR-T Therapy in Relapsed/Refractory Multiple Myeloma at European Hematology Association (EHA) Congress
SAN FRANCISCO and SUZHOU, China, June 8, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
2021-06-08 08:00
3823
Live from ASCO 2021 | Ascentage Pharma Delivers Oral Presentation Featuring Updated Data Demonstrating Promising Efficacy and Safety of Bcl-2 Inhibitor Lisaftoclax (APG-2575) in Patients with Relapsed or Refractory CLL/SLL
SUZHOU, China, and ROCKVILLE, MD, June 8, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today released updated results from the first...
2021-06-08 07:30
4471
Live from ASCO 2021 | Ascentage Pharma Presents Updated Results of MDM2-p53 Inhibitor Alrizomadlin (APG-115) Demonstrating an ORR of 24.1% Including Complete Response in Combination with Pembrolizumab in Patients with Advanced Melanoma Resistant or Refractory to Prior Immuno-Oncologic Drugs
SUZHOU, China, and ROCKVILLE, Md., June 8, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today presented in an oral presentation at t...
2021-06-08 07:21
11182
Second Global Health Forum of Boao Forum for Asia: A Call for Innovation and Collaboration to Promote the Progress of the Global Health System
QINGDAO, China, June 7, 2021 /PRNewswire/ -- Over 1,500 experts, scholars, government medical officials, and representatives of non-government organizations and pharmaceutical companies convened inQingdao for the second Global Health Forum ("GHF") of Boao Forum forAsia. The four-day affair, which...
2021-06-07 21:35
2445
ORTHO OPTIX™ Reader Completes Transfusion Medicine Portfolio, Now Available in the United States and Puerto Rico
RARITAN, N.J., June 7, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced its semi-automated ORTHO OPTIX™ Reader, which allows lower-volume transfusion labs to elevate their standard of patient care ...
2021-06-07 21:00
5931
Elekta's new strategy to focus on growth and access to radiation therapy
STOCKHOLM, June 7, 2021 /PRNewswire/ -- At Elekta's (EKTA-B.ST) Capital Markets Day, CEO,Gustaf Salford, and members from his executive management team introduced the company's mid-term strategy, called Access 2025. The strategy reflects the work the company will continue to do to pursue the visi...
2021-06-07 20:44
13425
RedHill Biopharma Completes Enrollment of Oral Opaganib Phase 2/3 COVID-19 Study
The global Phase 2/3 study of orally-administered opaganib for the treatment of severe COVID-19 enrolled a total of 475 patients, more than the planned 464 Opaganib is uniquely positioned as a leading novel, dual-action, investigational COVID-19 oral pill Blinded blended mortality rates encourag...
2021-06-07 19:00
4294
Device Companies will Drive Surgery Automation to Increase Elective Procedures in Western Europe
Western European selective medical devices market for elective procedures is expected to reach$16.8 billion by 2023 at a CAGR of 29.2%, finds Frost & Sullivan SANTA CLARA, Calif., June 7, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis, Impact of COVID-19 on Elective Procedures in Wester...
2021-06-07 18:02
1445
L'OCCITANE Race for Vision 2021: United Against Blindness
GENEVA, June 7, 2021 /PRNewswire/ -- Every year since 2016, the Race for Vision has brought together thousands of L'OCCITANE Group employees across the world. Its aim is to fight blindness in countries where many cases of vision loss could be prevented with appropriate screening or treatment. The...
2021-06-07 17:21
1836
Clarivate Forecasts Nearly 70% of North American, European and Asia Pacific Adult Populations Will Be Vaccinated for COVID-19 by September 2021
New report analyzes how the emergence and increased availability of vaccines will impact the recovery of healthcare markets across the globe LONDON, June 7, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of inn...
2021-06-07 16:15
6054
Elekta and Philips deepen strategic partnership in precise and individualized oncology care
STOCKHOLM and AMSTERDAM, June 7, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) and Royal Philips (NYSE: PHG, AEX: PHIA) today signed agreements to deepen their existing strategic partnership to advance comprehensive and personalized cancer care through precision oncology solutions. The extended collab...
2021-06-07 16:02
5849
Alodokter Raises Fresh Capital from MDI Ventures and Samsung Ventures to Grow Ecosystem
JAKARTA, Indonesia, June 7, 2021 /PRNewswire/ -- Alodokter, the No.1 digital health platform inIndonesia, has raised additional funding from MDI Ventures, a subsidiary of Telkom group and Samsung Ventures Investment Corporation (Samsung Ventures). MDI Ventures' ongoing support to Alodokter is a t...
2021-06-07 13:26
4319
Cigna Study Shows Uncertainty about the Future Continues to be the Leading Cause of Stress
HONG KONG, June 7, 2021 /PRNewswire/ -- Cigna Hong Kong today released the Hong Kong findings of the latest edition of its Cigna COVID-19 Global Impact Study. As part of Cigna's annual 360 Well-Being Survey, this research is the fifth in a series of studies to better understand the impact of the ...
2021-06-07 12:00
1922
China makes great efforts to contain COVID-19, saves more lives: SCO Secretary-General
WUHAN, China, June 4, 2021 /PRNewswire/ -- China has made great efforts to contain the spread of COVID-19 and saved more lives, Secretary-General of the Shanghai Cooperation Organization (SCO) Vladimir Norov told Global Times Online on the sidelines of the SCO non-governmental friendship forum he...
2021-06-07 11:35
1493
Alphamab Oncology Presents Phase 2 Clinical Data on KN046 Plus Paclitaxel/Cisplatin for the First-line Treatment of ESCC at ASCO 2021
SUZHOU, China, June 7, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced data from Phase 2 clinical study (KN046-204) of KN046(PD-L1/CTLA-4 bispecific antibody) plus paclitaxel/cisplatin for the first-line treatment of unresectable locally advanced, recurrent or metastatic e...
2021-06-07 10:11
6414
Alphamab Oncology Presents Phase 2 Clinical Data on KN046 Combined with Chemotherapy for the Treatment of Advanced NSCLC at ASCO 2021
* KN046 combined with platinum doublet chemotherapy is tolerated and has shown promising clinical benefit as IL treatment for stage IV NSCLC. * OS rate at 12 months and 15 months were both 74.9%; Similar survival was observed in patients with PD-L1≥1% and PD-L1<1%; * the median progression-f...
2021-06-07 10:10
6039
Week's Top Stories
Most Reposted
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality
[Picked up by 328 media titles]
2024-05-17 07:00Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 321 media titles]
2024-05-15 12:00
Innomix and World Castle Association Pioneer LBMR project at Zhangbi Fortress
[Picked up by 317 media titles]
2024-05-20 13:48
Samsung Electronics Unveils Month-Long Celebration of Esports Events for Students in Southeast Asia
[Picked up by 313 media titles]
2024-05-21 08:00
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 308 media titles]
2024-05-16 15:00
Most Read
Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
2024-05-15 12:00
13661
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
2024-05-16 15:00
13288
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
2024-05-16 09:39
12254
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality
2024-05-17 07:00
11058
Casio to Release G-SHOCK-Surfrider Foundation Collaboration
2024-05-15 09:00
10460
